Home » Topics » BioWorld Science, Patents

BioWorld Science, Patents
RSS

Chugai discloses erythromycins for gastrointestinal disorders

Nov. 27, 1996

Japanese researchers describe orally active antihypertensive agents

Nov. 27, 1996

New NO inhibitors disclosed by Fujisawa

Nov. 27, 1996

New taxane derivatives from Rhone-Poulenc Rorer

Nov. 27, 1996

New antioxidant from Shiseido shows CNS activity

Nov. 27, 1996

New cardiovascular agents claimed by Hoechst

Nov. 27, 1996

Takeda discloses new agents for neurodegenerative disorders

Nov. 27, 1996

Lilly claims 5-HT7 antagonist for GI indications

Nov. 26, 1996

HMG-CoA reductase inhibitors for preventing second heart attack

Nov. 26, 1996

Neuregulin polypeptides described for treating retinal disorders

Nov. 26, 1996

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 28, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for July 28, 2026
Brain-penetrant NLRP3 inhibitor shows promise in Parkinson’s
BioWorld Science
Researchers from Changchun Genescience Pharmaceuticals Co. Ltd. described the discovery and preclinical profile of an NLRP3 inhibitor with favorable brain...
Daybu readthrough in EU? Zevra’s NPC bid flounders
BioWorld
Zevra Therapeutics Inc. will try to follow in the footsteps of Acadia Pharmaceuticals Inc. with Rett syndrome drug Daybu (trofinetide) by asking the EMA’s...
Transcripta Bio raises funding to advance neuro pipeline
BioWorld Science
Transcripta Bio Inc. has raised $24 million since its series A to fund IND-enabling studies across its portfolio and support clinical preparation in its autism...